Nobuhiro Takeshima

Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602

Takashi Onda, Toyomi Satoh, Toshiaki Saito et al. · European Journal of Cancer · 2016 · 246 citations

Gynecologic Surgery, Surgical Oncology, Treatment Invasiveness +11

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García et al. · The Lancet · 2023 · 175 citations

Oncology, Cervical Cancer, Metronomic Therapy +6

Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma

Osamu Gotoh, Yuko Sugiyama, Yutaka Takazawa et al. · Nature Communications · 2019 · 146 citations · Full text

Somatic Variant, Tumor Heterogeneity, Medicine +14

Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer

Hiroyuki Kanao, Koji Matsuo, Yoichi Aoki et al. · Journal of Gynecologic Oncology · 2019 · 125 citations · Full text

Lymph node metastasis in ovarian cancer: Difference between serous and non-serous primary tumors

Nobuhiro Takeshima, Yasuo Hirai, Kenji Umayahara et al. · Gynecologic Oncology · 2005 · 123 citations

Lymphoid Neoplasia, Tumoral Pathology, Medicine +7